Latest Bisphosphonate Stories
Treatment costs estimated at $2 billion annually, or $205,500 per avoided hip fracture LAS VEGAS, March 24, 2015 /PRNewswire-USNewswire/ --
Drs. Robert Lindsay and Paul Miller Co-Chair Group Working to Standardize Bone Turnover Markers for Use in Clinical Practice WASHINGTON, Jan.
Discrepancy increases risk for future bone breaks, related complications ROSEMONT, Ill., Nov.
MOSCOW, October 28, 2014 /PRNewswire/ -- Osteros Biomedica Ltd., a joint venture company of Maxwell Biotech Group and MBC Pharma Inc., and formed with the participation
ROSEMONT, Ill., June 18, 2014 /PRNewswire-USNewswire/ -- A new position paper on Medication Related Osteonecrosis of the Jaw (MRONJ) released by the American Association of Oral and Maxillofacial Surgeons,
--Recently Revised Label for Marketed Calcitonin Products Has Helped Clarify the Regulatory Landscape in the U.S.-- PHILADELPHIA, May 29, 2014 /PRNewswire/ -- Tarsa Therapeutics,
-Files patents on markers- TEL AVIV, Israel, May 27, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd.
PISA, Italy and HONG KONG, May 26, 2014 /PRNewswire/ -- Abiogen Pharma S.p.A.
A new report launched today by the International Osteoporosis Foundation (IOF) shows that osteoporosis is a serious problem throughout the Asia Pacific, with the number of fracture sufferers to rise dramatically in the coming decades.
- a slit in a tire to drain away surface water and improve traction.